Doha, 05 May 2025: As part of its ongoing Your Health, Our Priority campaign, Hamad Medical Corporation (HMC) is proud to highlight the exceptional services provided by its Dermatology Department — one of the region’s leading centers for skin health.
HMC’s Dermatology and Venereology Department provides high-quality medical care for patients of all ages with all skin conditions including eczemas, psoriasis, hair fall, vitiligo, skin infections, immune and allergic processes, skin cancer, and other skin manifestations. As a regional hub for outstanding patient care, the department is also building a global reputation for innovation, multidisciplinary collaboration, and groundbreaking research in skin science.
“Our dermatology services reflect HMC’s broader commitment to delivering specialized, world-class healthcare to the community of Qatar,” said Prof. Martin Steinhoff, Chairman of its Dermatology and Venereology Department, and one of the top 2% ranked researchers worldwide by Stanford University, “Whether treating common skin conditions or managing the most complex diseases, our goal is always to provide personalized, the most updated high-quality care tailored to the needs of each patient.”
Patients have the benefit of accessing cutting-edge treatments delivered by expert clinicians across a wide range of subspecialty clinics at HMC, including:
- Biologic and immunomodulatory therapies for inflammatory skin diseases such as atopic dermatitis, psoriasis, vitiligo, autoimmune diseases.
- Hair and scalp clinics for complex disorders such as alopecia areata and scarring alopecia.
- State-of-the-art light-based treatments for conditions such as vitiligo, atopic dermatitis, psoriasis, and cutaneous T-cell lymphoma.
- Dermato-surgery treatments including skin biopsies and excisions for benign and malignant lesions.
- Advanced laser therapy for scarring, pigmentation disorders, and rosacea.
- Sclerotherapy and foam sclerotherapy for the treatment of venous insufficiencies such as varicose veins, spider veins, and deep vein thrombosis.
- Skin cancer diagnostics and therapy of benign and malignant skin cancers.
- Genetic dermatology and genodermatoses for diagnostics and therapy of genetic skin diseases and haemangiomas.
Specialized clinics also include services for pediatric dermatology, geriatric dermatology (one of the first globally), sexually transmitted infections, and complex autoimmune skin diseases.
The latest advanced technology at HMC allows for real-time skin imaging and non-invasive diagnostics, such as dermoscopy or ultrasound, enabling earlier and more accurate detection of conditions like melanoma and other skin cancers or scleroderma — improving outcomes and reducing the need for unnecessary procedures.
HMC’s dermatology specialists are expertly trained, playing a crucial role in emergency and inpatient care to manage severe, life-threatening skin conditions such as Stevens-Johnson-Syndrome, erythroderma, drug reactions, allergies, and autoimmune diseases.
Dr. Ayda Al Hammadi, Senior Consultant at HMC’s Dermatology and Venereology Department shared that “our vision is to be more than just a center for treatment. We aim to set new standards for dermatological care and to serve as a model for excellence globally.”
Dr. Sara Al-Khawaga, Specialist in Dermatology at HMC added, “We integrate the latest scientific advances with compassionate care, ensuring that each patient receives the most effective treatment.”
“Outstanding patient care and research at the Dermatology and Venereology Department is underpinned by an extensive residency program” stated Dr. Aysha Al-Malki, Dermatology Residency Program Director.
The internationally highly ranked state-of-the-art research at the Dermatology Institute ensures excellence in understanding and better treating skin diseases precision medicine-based in the future.
Through its commitment to innovation, education, research, residency training, and compassionate care, HMC’s Dermatology Department continues to deliver world-class services — ensuring that the health and well-being of every patient remain a top priority.
